Blog

Jan 12, 2025, 19:44

Patrick Hwu: Celebrating the grand opening of Moffitt at South Shore

Patrick Hwu shared on LinkedIn:

“Today, we celebrated the grand opening of Moffitt at SouthShore, marking a pivotal milestone in our journey to provide world-class cancer care to those who need it most.

This state-of-the-art facility in Ruskin, FL, reflects our unwavering commitment to advancing cancer care. From diagnostic imaging and medical oncology clinics to cutting-edge clinical trials, infusion and radiation, Moffitt at SouthShore is poised to serve nearly 9,000 patients in its first five years, bringing life-saving treatment closer to the communities we serve in south Hillsborough County.

This achievement would not have been possible without the collective efforts of many: H. Lee Moffitt, whose vision laid the foundation for everything we do. Congressman Vern Buchanan, whose support helped secure critical funding for this project.

Tim Adams and our Board of Directors, for their leadership and guidance. Jazmin Calzada, Matt Bednar, and the SouthShore project team for their tireless dedication to this project. Sabi Singh and Karen Lu, for their leadership. Justin Menendez and our partners at The Whiting-Turner Contracting Company, BECK ARCHITECTURE and others.

I’d also like to thank our elected officials, community leaders, and incredible Moffitt Cancer Center team members for their unwavering support.

Moffitt at SouthShore is not just a facility—it’s a step toward delivering hope, innovation and world-class care within our community. Together, we are delivering on Moffitt’s mission to contribute to the prevention and cure of cancer.”

Patrick Hwu: Celebrating the grand opening of Moffitt at South Shore

Dr. Patrick Hwu, MD, currently serves as the President and CEO of Moffitt Cancer Center. With a focus on understanding the dynamics between tumors and the immune system, Dr. Hwu’s research has been pivotal in advancing gene-modified T-cell therapy.

He notably contributed seminal work on the development of the first chimeric antigen receptor aimed at combating cancer. His research portfolio extends to vaccines, adoptive T-cell therapies, and mechanisms of immune resistance.

Before joining, Dr. Hwu held numerous leadership roles at The University of Texas MD Anderson Cancer Center for over 17 years.

Notably, he served as the inaugural Chairman of the Department of Melanoma Medical Oncology in 2003, as well as the Associate Director of the Center for Cancer Immunology Research. Additionally, he chaired the Department of Sarcoma Medical Oncology, demonstrating his commitment to advancing cancer treatment and research.